PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
320.7K views | +3 today
Follow

EDetailing for Idiots

From www.basearticles.com

Article from Base Articles and entitled An Anatomy of EDetailing for Idiots - By anna smith
eMedToday's curator insight, June 11, 2013 11:23 PM

summary:

 

"Among all these above mentioned activities virtual detailing is the most frequent of all and there can be hardly any doubt that if executed properly this particular activity can result in a number of important benefits like"


12 benefits are listed. All sound. 

Eli Lilly Gets It Right

From news.google.com

Eli Lilly backs mobile app for cancer docs FierceBiotech IT The pharma giant has sponsored a mobile app for iPhone and Android devices that provides reviews of journal articles, aiming to help keep busy physicians abreast of the latest research in...
eMedToday's curator insight, June 5, 2013 7:55 AM

This is a brilliant approach to development of mobile app. Essentially Pharmas should develop mobile apps which are organized around their disease focus and which gather the best, trusted journel information for a doctor to review. This could be done as a stand alone app or on an e detailing platform

 

Eli Lilly ($LLY) has invested more in digital overtures to cancer specialists. The pharma giant has sponsored a mobile app for iPhone and Android devices that provides reviews of journal articles, aiming to help keep busy physicians abreast of the latest research in their areas of specialty or interest.

Patrick Graziano's curator insight, June 5, 2013 1:23 PM

#digipharma, #digitalmarketing, 

Pharma Marketing Blog: Tablet Detailing Evolution

From pharmamkting.blogspot.com

The Roche "Team Italy" (see below) sent me a nice infographic that provides some details about the current and future digital efforts of Roche Italy -- including some data regarding digital marketing spend by various brands.
eMedToday's curator insight, May 26, 2013 6:16 AM

Good short discussion of Roche evolution for e detailing. For them, it is here and not and impressive